MedTrace Logo

Treatment of Incontinence Without Memory Problems

NCT02436889 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2019-04-16

Study results available
· View outcomes & findings →

Summary

An 8-week randomized, controlled, pilot clinical trial of Mirabegron compared to a standard anticholinergic therapy (Detrol LA) in elderly women with urgency urinary incontinence.

Conditions

  • Urge Incontinence
  • Urinary Incontinence, Urge

Interventions

DRUG

Mirabegron

DRUG

Tolterodine Tartrate

Sponsors & Collaborators

Principal Investigators

  • Leslee Subak, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-12-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436889 on ClinicalTrials.gov